EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)

Completed · Phase 2

Conditions studied: Edematous Fibrosclerotic Panniculopathy, Cellulite

In brief

A Phase 2, Open-Label Extension Study of EN3835 in the Treatment of Edematous Fibrosclerotic Panniculopathy (commonly known as Cellulite).

Key facts

Study ID

NCT02942160

Run by

Endo USA Inc., a Keenova Therapeutics Company

People needed

259

Starts

2016-10-05

Expected to finish

2018-06-14

Last updated by the study team

2020-11-24

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Endo Clinical Trial Site #1 — Beverly Hills, California, United States
• Endo Clinical Trial Site #2 — Murrieta, California, United States
• Endo Clinical Trial Site #3 — Oceanside, California, United States
• Endo Clinical Trial Site #4 — San Diego, California, United States
• Endo Clinical Trial Site #5 — Clearwater, Florida, United States
• Endo Clinical Trial Site #6 — Coral Gables, Florida, United States
• Endo Clinical Trial Site #7 — Palm Beach, Florida, United States
• Endo Clinical Trial Site #8 — Washington, Missouri, United States
• Endo Clinical Trial Site #10 — New York, New York, United States
• Endo Clinical Trial Site #9 — New York, New York, United States
• Endo Clinical Trial Site #11 — Nashville, Tennessee, United States
• Endo Clinical Trial Site #12 — Pflugerville, Texas, United States
• Endo Clinical Trial Site #13 — Charlottesville, Virginia, United States
• Endo Clinical Trial Site #14 — Lynchburg, Virginia, United States
• Endo Clinical Trial Site #15 — Spokane, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.